Reshape Lifesciences Stock Technical Analysis
| RSLS Stock | USD 5.56 0.12 2.11% |
As of the 28th of November, ReShape Lifesciences holds the Market Risk Adjusted Performance of (2.02), risk adjusted performance of (0.06), and Coefficient Of Variation of (1,130). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ReShape Lifesciences, as well as the relationship between them. Please check ReShape Lifesciences risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and kurtosis to decide if ReShape Lifesciences is priced some-what accurately, providing market reflects its current price of 5.56 per share. Given that ReShape Lifesciences has information ratio of (0.11), we recommend you to check out ReShape Lifesciences's recent market performance to make sure the company can sustain itself at a future point.
ReShape Lifesciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ReShape, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ReShapeReShape |
ReShape Lifesciences Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 4.0 | Hold | 1 | Odds |
Most ReShape analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ReShape stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ReShape Lifesciences, talking to its executives and customers, or listening to ReShape conference calls.
ReShape Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ReShape Lifesciences Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ReShape Lifesciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
ReShape Lifesciences Trend Analysis
Use this graph to draw trend lines for ReShape Lifesciences. You can use it to identify possible trend reversals for ReShape Lifesciences as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual ReShape Lifesciences price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.ReShape Lifesciences Best Fit Change Line
The following chart estimates an ordinary least squares regression model for ReShape Lifesciences applied against its price change over selected period. The best fit line has a slop of 0.05 , which may suggest that ReShape Lifesciences market price will keep on failing further. It has 122 observation points and a regression sum of squares at 105.48, which is the sum of squared deviations for the predicted ReShape Lifesciences price change compared to its average price change.About ReShape Lifesciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ReShape Lifesciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ReShape Lifesciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ReShape Lifesciences price pattern first instead of the macroeconomic environment surrounding ReShape Lifesciences. By analyzing ReShape Lifesciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ReShape Lifesciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ReShape Lifesciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 1.51 | 2.3 | 1.85 | 1.95 | Days Of Inventory On Hand | 208.7 | 296.98 | 436.25 | 414.44 |
ReShape Lifesciences November 28, 2024 Technical Indicators
Most technical analysis of ReShape help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ReShape from various momentum indicators to cycle indicators. When you analyze ReShape charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (2.02) | |||
| Mean Deviation | 4.83 | |||
| Coefficient Of Variation | (1,130) | |||
| Standard Deviation | 6.9 | |||
| Variance | 47.63 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (0.66) | |||
| Total Risk Alpha | (1.66) | |||
| Treynor Ratio | (2.03) | |||
| Maximum Drawdown | 42.57 | |||
| Value At Risk | (10.12) | |||
| Potential Upside | 7.93 | |||
| Skewness | 0.1821 | |||
| Kurtosis | 2.85 |
Additional Tools for ReShape Stock Analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.